Avivagen Inc. (VIVXF)
Market Closed
11 Aug, 20:00
OTCQB OTCQB Primary $
0. 00
0
0%
$
7.77K Market Cap
- P/E Ratio
- Div Yield
100 Volume
0 Eps
$ 0
Previous Close Want to track VIVXF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
VIVXF closed yesterday higher at $0, an increase of 0% from Monday's close, completing a monthly increase of 0% or $0. Over the past 12 months, VIVXF stock gained 0%.
VIVXF is not paying dividends to its shareholders.
The last earnings report, released on Mar 20, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Avivagen Inc. has completed 1 stock splits, with the recent split occurring on May 25, 2017.
The company's stock is traded on one exchange.
Avivagen Inc. (VIVXF) FAQ
What is the stock price today?
The current price is $0.00.
On which exchange is it traded?
Avivagen Inc. is listed on OTCQB.
What is its stock symbol?
The ticker symbol is VIVXF.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 7.77K.
Has Avivagen Inc. ever had a stock split?
Avivagen Inc. had 1 splits and the recent split was on May 25, 2017.
Avivagen Inc. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | G. F. Kym Anthony CEO | OTCQB Exchange | 05382F202 CUSIP |
| CA Country | 13 Employees | - Last Dividend | 25 May 2017 Last Split | - IPO Date |
Overview
Avivagen Inc. is a company dedicated to the innovation and commercialization of products designed for livestock feeds, aiming to enhance immune function and facilitate optimal growth and productivity in animals. Incorporated in 2005 and based in Ottawa, Canada, Avivagen has made significant strides in the animal health and nutrition industry. The company extends its services across numerous countries, including Canada, Mexico, Brazil, the Philippines, Taiwan, and Thailand, showcasing its global commitment to improving livestock well-being through scientific advancements.
Products and Services
- OxC-beta Livestock: A premix designed for inclusion in livestock feeds. OxC-beta Livestock is formulated to support animal immune function, an essential factor for optimal health and performance in livestock production. By nurturing stronger immune systems, this product aids in improving the overall health and productivity of animals, leading to enhanced efficiency in livestock operations.
- Vivamune Health Chews for Dogs: These chews are a dietary supplement designed to support the health and well-being of dogs. Packed with nutrients that promote immune health, vitality, and a vibrant coat, Vivamune Health Chews offer a convenient and tasty way to ensure dogs receive the essential elements they need for a healthy life.
- Dr. Tobias Dog Chews: Another line of health supplements for dogs, the Dr. Tobias Dog Chews are formulated to provide a range of health benefits. These chews are designed to support various aspects of canine well-being, from immune function to joint health, ensuring dogs lead happy, active, and healthy lives.
- Dr. Tobias Beta Blend for the Human Immune System: Diverging into human health, Avivagen offers the Dr. Tobias Beta Blend, a product specially formulated to support the human immune system. This blend provides a combination of nutrients aimed at bolstering human health, highlighting Avivagen’s commitment to fostering well-being across species.
Contact Information
Address: 100 Sussex Drive
Phone: +1 613 949 8164
Website: https://www.avivagen.com
